Settings
Save and close
Step into the future of oncology research with our next generation sequencing (NGS) assay. Unlock information behind 517 vital cancer-related genes, delving deep into the core of DNA and RNA variant exploration. Seamlessly uncover SNVs, CNVs, indels, and fusions, alongside comprehensive insights into MSI and TMB - all in a single, dynamic package.
Explore the full spectrum of gene expression with comprehensive transcriptome coverage. Our RNA-Seq technology offers unparalleled flexibility and scalability. Customize your experimental design to fit your research goals and scale up seamlessly for in-depth analyses across diverse biological contexts.
Discover genetic variations amongst your study cohort from rare mutations to common polymorphisms usingJAX APML's cutting edge technology combined with our analytics expertise.
From delving into rare disease to exploring therapeutic targets our whole genome sequencing service equips you with the data you need to drive research forward. State-of-the-art technology ensures accuracy and completeness.
*All services include subtraction of murine background.
To aid functional interpretation, detailed annotations of variants based on several genomic, functional, and population datasets including dbSNP, COSMIC, Ensembl, UCSC, the 1000 Genomes project, NHLBI Exome Sequencing Project (ESP), the Exome Aggregation Consortium (ExAC), PolyPhen, SIFT, PhyloP, and many more will be provided.